| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |